CGHS payment uncertainty and policy changes
Management expressed caution on CGHS due to non-predictability of payments and potential circular changes, despite recent rate increases.
medium · analyst_question
Fortis Healthcare Limited — Q2 FY26
Fortis Healthcare delivered a strong Q2 FY26 with consolidated revenue of INR 2,331 crore (+17.3% YoY) and EBITDA margin expansion of 200 bps to 23.9%.
bullish
high
✓ Verified against BSE filing
Risk Intelligence
Material risks this quarter
Concise cards keep the risk register scannable while preserving evidence-level context in the underlying quarter data.
Risks
Integration risk from Gleneagles O&M agreement
The O&M arrangement for five hospitals may face operational challenges; future conversion to ownership is uncertain.
medium · analyst_questionDebt increase from acquisitions
Net debt rose to INR 2,219 crore (0.96x EBITDA) from 0.16x a year ago due to acquisitions, though management is comfortable.
low · data_observationDelay in SMRI capacity addition
Commissioning of 225 beds at SMRI delayed by three months to March 2026, pushing revenue contribution to next fiscal.
low · management_commentary